EP3233054
EFNABLÖNDUR PI3K/MTOR-HEMILS TIL LYFJAGJAFAR Í BLÁÆÐ
Status:
EP einkaleyfi í gildi á ÍslandiEP appl. date:
10.12.2015EP published:
30.6.2021EP application number:
15813578.0
EP translation filed:
20.7.2021Grant published:
15.9.2021EPO information:
European Patent Register
Max expiry date:
9.12.2035Expiry date:
9.12.2026Next due date:
31.12.2026
Title:
FORMULATIONS OF A PI3K/MTOR-INHIBITOR FOR INTRAVENOUS ADMINISTRATION
Timeline
Today
10.12.2015EP application
30.6.2021EP Publication
20.7.2021Translation submitted
15.9.2021Registration published
9.12.2026Expires
Owner
Name:
Pfizer Inc.Address:
235 East 42nd Street, New York, NY 10017, US
Inventor
Name:
BACK, Kevin RichardAddress:
Sandwich Kent CT13 9NJ, GB
Name:
CRAM, MichaelAddress:
Sandwich Kent CT13 9NJ, GB
Name:
HARPER, Aidan JamesAddress:
Sandwich Kent CT13 9NJ, GB
Name:
HUANG, W. JamesAddress:
Somerville, New Jersey 08876, US
Name:
LILLIS, Jonathan RichardAddress:
Sandwich Kent CT13 9NJ, GB
Name:
LUKAS, Timothy MichaelAddress:
Sandwich Kent CT13 9NJ, GB
Name:
LUTHRA, SumitAddress:
Westford, Massachusetts 01886, US
Agent
Name:
Tego ehf.Address:
Pósthólf 8129, 128, Reykjavík,
Priority
Number:
201462093060 PDate:
17.12.2014Country:
US
Number:
201562250633 PDate:
4.11.2015Country:
US
Classification
Categories:
A61K 9/00, A61K 47/02, A61K 47/12, A61K 47/26, A61K 9/08, A61K 9/19, A61K 31/5377, A61P 35/00
Annual fees
Number
Paid
Expires
Payer
Number: 7
Paid: 10.9.2021
Expires: 9.12.2022
Payer: Tego ehf.
Number: 8
Paid: 21.11.2022
Expires: 9.12.2023
Payer: Árnason Faktor ehf.
Number: 9
Paid: 23.11.2023
Expires: 9.12.2024
Payer: Árnason Faktor ehf.
Number: 10
Paid: 20.11.2024
Expires: 9.12.2025
Payer: Árnason Faktor ehf.
Number: 11
Paid: 11.12.2025
Expires: 9.12.2026
Payer: Árnason Faktor ehf.